Fasiplon
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 106100-65-6 |
PubChem (CID) | 208954 |
ChemSpider | 181047 |
UNII | XCA050IPGB |
ChEMBL | CHEMBL62735 |
Chemical and physical data | |
Formula | C13H15N5O2 |
Molar mass | 273.290 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Fasiplon (RU 33203) is a nonbenzodiazepine anxiolytic drug from the imidazopyrimidine family of drugs.
Fasiplon binds strongly to benzodiazepine sites on the GABAA receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action.[1] It was developed by a team at Roussel Uclaf in the 1990s[2]
References
- ↑ Tully WR, Gardner CR, Gillespie RJ, Westwood R (July 1991). "2-(oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors". Journal of Medicinal Chemistry. 34 (7): 2060–7. doi:10.1021/jm00111a021. PMID 1648620.
- ↑ US Patent 5869481 Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
This article is issued from Wikipedia - version of the 9/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.